Volume Rendering of Myocardium, Cardiac Valves Enables Visualization
Medically reviewed by Drugs.com
via HealthDayFRIDAY, Feb. 20, 2026 -- Rapid and dynamic visualization of valves and myocardium is possible using volume rendering of three-dimensional (3D) cardiac magnetic resonance imaging (MRI) and four-dimensional (4D) cine and flow images in pediatric patients, according to a study published online Feb. 12 in Radiology: Cardiothoracic Imaging.
Julia Iacovella, from The Children's Hospital of Philadelphia, and colleagues conducted a retrospective study to develop a volume rendering method to visualize myocardial structures and blood flow using 3D, 4D cine, and 4D flow cardiac MRI. The custom transfer functions for volume rendering and novel dense streamline-based 4D flow visualizations were developed and implemented in the 3D Slicer image computing platform, and were then applied to the cardiac MRI studies of four pediatric patients with congenital heart disease.
The researchers demonstrated applications in four patients, which included integration into interventional planning workflows. Rapid and dynamic 3D and 4D visualization of the myocardium and valves was enabled by cardiac MRI in less than 1 second; image refinement was completed in less than three minutes. The simultaneous depiction of valve dynamics, regurgitation, and stenosis was allowed by integration of tissue rendering with 4D flow visualization.
"Volume rendering is fast -- generating visualizations nearly instantaneously -- which is essential for 4D moving images where there is simply too much information to process using traditional manual tracing methods," coauthor Matthew A. Jolley, M.D., also from The Children's Hospital of Philadelphia, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-02-21 15:58
Read more
- Moderna’s mRNA Flu Vaccine Back Under FDA Review
- Overweight, Obesity Remained Highly Prevalent in U.S. Youths in 2024
- U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 1
- Risk Factors Associated With Child Food Allergy Identified
- BJ’s Wholesale Club Issues Salmon Recall Across Seven East Coast States
- FDA Approves Adquey (difamilast 1%) Ointment for the Treatment of Mild-to-Moderate Atopic Dermatitis
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions